Section 13-3203 – Membership [Subtitle Subject to Abrogation]
// EFFECTIVE UNTIL SEPTEMBER 30, 2024 PER CHAPTERS 410 AND 411 OF 2019 // (a) The Council consists of the following members: (1) One member of the Senate of Maryland, appointed by the President of the Senate; (2) One member of the House of Delegates, appointed by the Speaker of the House; (3) The Secretary of Health, or the […]
Section 13-3204 – Chair; Compensation; Reimbursement for Expenses [Subtitle Subject to Abrogation]
// EFFECTIVE UNTIL SEPTEMBER 30, 2024 PER CHAPTERS 410 AND 411 OF 2019 // (a) The members of the Council shall select the chair of the Council. (b) A member of the Council: (1) May not receive compensation as a member of the Council; but (2) Is entitled to reimbursement for expenses under the Standard State Travel Regulations, as […]
Section 13-3205 – Staff [Subtitle Subject to Abrogation]
// EFFECTIVE UNTIL SEPTEMBER 30, 2024 PER CHAPTERS 410 AND 411 OF 2019 // (a) The Department, with assistance from the Department of Aging, shall provide staff support for the Council. (b) The Department may request staffing assistance from public health entities with an interest in the duties of the Council.
Section 13-3206 – Duties [Subtitle Subject to Abrogation]
// EFFECTIVE UNTIL SEPTEMBER 30, 2024 PER CHAPTERS 410 AND 411 OF 2019 // The Council shall: (1) Update the State Plan on Alzheimer’s Disease and Related Disorders and advocate for the State Plan; (2) (i) Examine the needs of individuals with Alzheimer’s disease and related disorders and their caregivers; and (ii) Identify methods through which the State can […]
Section 13-3207 – Report [Subtitle Subject to Abrogation]
// EFFECTIVE UNTIL SEPTEMBER 30, 2024 PER CHAPTERS 410 AND 411 OF 2019 // On or before September 1 each year, the Council shall report to the Governor and, in accordance with § 2–1257 of the State Government Article, the General Assembly on the activities and recommendations of the Council.
Section 13-3101 – Definitions
(a) In this subtitle the following words have the meanings indicated. (b) “Pharmacist” has the meaning stated in § 12–101 of the Health Occupations Article. (c) “Private or public entity” means a health care provider, local health department, community–based organization, substance abuse treatment organization, or other person that addresses medical or social issues related to drug addiction. (d) “Program” […]
Section 13-3301 – Definitions
(a) In this subtitle the following words have the meanings indicated. (b) “Academic research representative” means an employee or agent of an institution of higher education, a related medical facility, or an affiliated biomedical research firm that filed a registration with the Commission under § 13–3304.1 of this subtitle who is authorized to purchase medical cannabis for […]
Section 13-3102 – Purpose
The Overdose Response Program is a program administered by the Department for the purpose of providing a means of authorizing certain individuals to administer naloxone to an individual experiencing, or believed to be experiencing, opioid overdose to help prevent a fatality when medical services are not immediately available.
Section 13-3301.1 – Legislative Intent
The General Assembly intends that the programs implemented in accordance with this subtitle yield a successful but consumer–friendly medical cannabis industry in the State to provide patients affordable and adequate access to medical cannabis.
Section 13-3103 – Powers and Duties of Department
(a) The Department shall adopt regulations necessary for the administration of the Program. (b) The Department may: (1) Collect fees necessary for the administration of the Program; (2) Authorize private or public entities to conduct education and training on opioid overdose recognition and response that include: (i) Education on recognizing the signs and symptoms of an opioid overdose; (ii) Training on […]